Kent Bondensgaard
11Patents
5h-index
4Co-inventors
55Inventor score
Filing activity: Apr 18, 2006 → Mar 30, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8470979B2 | Humanized antibody molecules specific for IL-31 | Chemistry; Metallurgy | 31 | Active |
| US8211420B2 | Interleukin-21 variants with altered binding to the IL-21 receptor | Human Necessities | 23 | Active |
| US8034326B2 | IL-21 variants | Human Necessities | 14 | Active |
| US8685669B2 | Nucleic acid molecules encoding humanized antibody molecules specific for IL-31 | Chemistry; Metallurgy | 8 | Active |
| US9005921B2 | Polynucleotides encoding IL-31 monoclonal antibodies | Chemistry; Metallurgy | 6 | Active |
| US9416184B2 | Method of treating pruritus with IL-31 monoclonal antibodies | Chemistry; Metallurgy | 5 | Active |
| US8475784B2 | IL-21 variants | Human Necessities | 4 | Active |
| US9982044B2 | Method of treating pruritus with IL-31 monoclonal antibody formulations | Chemistry; Metallurgy | 1 | Active |
| US10640559B2 | Nucleic acid molecules encoding humanized IL-31 monoclonal antibodies | Chemistry; Metallurgy | 0 | Active |
| US11542327B2 | Methods of treating pruritic disease with IL-31 monoclonal antibodies | Chemistry; Metallurgy | 0 | Active |
| US9738715B2 | IL-31 monoclonal antibody formulations | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.